Market closedNon-fractional

AtriCure/ATRC

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About AtriCure

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Ticker

ATRC

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Mason, United States

Employees

1,200

AtriCure Metrics

BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.80
EPS
1.37
Beta
-
Dividend rate
$1.1B
1.37
4.004
2.633
15.959
16.516
-5.23%
-3.86%
-8.17%
2.51
2.31
6.61
-42.08
18.70%
-3.13%
24.94%
-10.35%

What the Analysts think about AtriCure

Analyst Ratings

Majority rating from 9 analysts.
Buy

AtriCure Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-12.13% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$109M
2.16%
Net income
-$13M
36.08%
Profit margin
-12.13%
33.30%

AtriCure Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 22.57%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.11
-$0.20
-$0.21
-$0.28
-
Expected
-$0.30
-$0.31
-$0.23
-$0.23
-$0.17
Surprise
-62.77%
-35.79%
-8.50%
22.57%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for AtriCure stock?

AtriCure (ATRC) has a market cap of $1.1B as of July 05, 2024.

What is the P/E ratio for AtriCure stock?

The price to earnings (P/E) ratio for AtriCure (ATRC) stock is 0 as of July 05, 2024.

Does AtriCure stock pay dividends?

No, AtriCure (ATRC) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next AtriCure dividend payment date?

AtriCure (ATRC) stock does not pay dividends to its shareholders.

What is the beta indicator for AtriCure?

AtriCure (ATRC) has a beta rating of 1.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell AtriCure stock

Buy or sell AtriCure stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing